Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 an... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
0
Authors
Elizabeth England
26 more
Elizabeth England
•
Ian Scott
24 more
•
E. Cohen
Published
March 1, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Neuroscience
Chemistry
Medicine
Immunology
Show all topics
DOI
10.1101/2023.02.28.527262
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Neuroscience
Chemistry
Medicine
Immunology
Show all topics
DOI
10.1101/2023.02.28.527262
License
CC-BY
Other Formats
PDF
